ENOLOTAX 250 MG 50 CAP

FOR THE PROPHYLAXIS OF ORGAN REJECTION IN PATIENTS RECEIVING ALLOGENEIC RENAL, CARDIAC OR HEPATIC TRANSPLANTS. IT SHOULD BE USED CONCOMITANTLY WITH CYCLOSPORINE AND CORTICOSTEROIDS.